GGrantIndex
Sort

27,075 grants matching cholesterol

Molecular Basis of Exercise-induced Changes in HDL Function

$777,672
Mark Andrew Sarzynski · University Of South Carolina At Columbia · R01 · FY2021 · HL

HIT for Facilitating Problem Solving in Diabetes Management

$777,630
George M. Hripcsak · Columbia University Health Sciences · R01 · FY2011 · DK

LPS Signaling in Macrophages: The Roll of Toll

$777,606
Alan A Aderem · Seattle Children'S Hospital · R01 · FY2018 · AI

Intracoronary imaging of plaque collagen in patients

$777,572
Seemantini K Nadkarni · Massachusetts General Hospital · R01 · FY2014 · HL

Colorado Center for Childhood Liver Disease Research and Education

$777,405
Ronald J Sokol · University Of Colorado Denver · U01 · FY2009 · DK

Epigenetic Reprogramming in HIV-Associated Cardio-Vascular Disease

$777,389
Michael Ilya Bukrinsky · George Washington University · R01 · FY2021 · HL

HDL Proteins and Coronary Heart Disease

$777,358
Frank M Sacks · Harvard School Of Public Health · R01 · FY2015 · HL

Mitochondrial DNA Copy Number and Genetic Variation in Coronary Heart Disease

$777,159
Dan E Arking · Johns Hopkins University · R01 · FY2019 · HL

Post-transcriptional regulation of LDLR

$777,112
Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2024 · HL

Reducing Total Cardiovascular Risk in an Urban Community

$777,045
Jerilyn K Allen · Johns Hopkins University · R01 · FY2007 · HL

Development of AAV-AIBP for neuroprotection in glaucoma

$776,782
Wonkyu Ju · University Of California, San Diego · UG3 · FY2023 · NS

Genetics and Triglycerides: opportunities for new approaches to identify therapies

$776,673
Qiping Feng · Vanderbilt University Medical Center · R01 · FY2023 · HL

Genetics and Triglycerides: opportunities for new approaches to identify therapies

$776,673
Qiping Feng · Vanderbilt University Medical Center · R01 · FY2025 · HL

The Risk of Myocardial Infarction in Patients with Psoriasis

$776,528
Joel M Gelfand · University Of Pennsylvania · R01 · FY2011 · HL

Impaired Vasoreactivity, Sleep Degradation, and Impaired Clearance in the APOE4 Brain

$776,419
Elizabeth A Proctor · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · AG

Primary Care Obesity Prevention: One or Multiple Targets

$776,323
Nicolas Stettler · Children'S Hosp Of Philadelphia · R01 · FY2007 · HL

Lifestyle effects on hematopoiesis and atherosclerosis

$776,297
Filip K Swirski · Massachusetts General Hospital · R01 · FY2015 · HL

Allopregnanolone a Regenerative Therapy for Alzheimer's: FDA-Required Toxicolog

$776,163
Roberta Diaz Brinton · University Of Southern California · U01 · FY2015 · AG

Community Translation of the South Asian Healthy Lifestyle Intervention (SAHELI)

$776,078
Namratha R Kandula · Northwestern University At Chicago · R01 · FY2017 · HL

Endosome Dysfunction in Alzheimer's Disease

$775,998
Ralph A. Nixon · New York University School Of Medicine · R01 · FY2018 · AG

ApoE receptor-2 in vascular disease progression and regression

$775,946
David Y Hui · University Of Cincinnati · R01 · FY2021 · HL

Health Promoters and Pharmacists in Diabetes Team Management

$775,810
Ben Steven Gerber · University Of Illinois At Chicago · R01 · FY2011 · DK

Functional Analysis of Novel Genes in Eye Development and Vision

$775,691
Graeme J Wistow · National Eye Institute · ZIA · FY2015 · EY

REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-2

$775,564
Monika M Safford · University Of Alabama At Birmingham · R01 · FY2012 · HL

Sugar-sweetened beverages and cardiovascular disease risk: an RCT

$775,526
David S Ludwig · Boston Children'S Hospital · R01 · FY2010 · HL